Quantitation of DNA methylation in Epstein-Barr virus–associated nasopharyngeal carcinoma by bisulfite amplicon sequencing

Background Epigenetic changes, including DNA methylation, disrupt normal cell function, thus contributing to multiple steps of carcinogenesis. Nasopharyngeal carcinoma (NPC) is endemic in southern China and is highly associated with Epstein-Barr virus (EBV) infection. Significant changes of the host...

Full description

Saved in:
Bibliographic Details
Published inBMC cancer Vol. 17; no. 1; pp. 489 - 9
Main Authors Zhao, Weilin, Mo, Yingxi, Wang, Shumin, Midorikawa, Kaoru, Ma, Ning, Hiraku, Yusuke, Oikawa, Shinji, Huang, Guangwu, Zhang, Zhe, Murata, Mariko, Takeuchi, Kazuhiko
Format Journal Article
LanguageEnglish
Published London BioMed Central 17.07.2017
BioMed Central Ltd
BMC
Subjects
DNA
Online AccessGet full text
ISSN1471-2407
1471-2407
DOI10.1186/s12885-017-3482-3

Cover

More Information
Summary:Background Epigenetic changes, including DNA methylation, disrupt normal cell function, thus contributing to multiple steps of carcinogenesis. Nasopharyngeal carcinoma (NPC) is endemic in southern China and is highly associated with Epstein-Barr virus (EBV) infection. Significant changes of the host cell methylome are observed in EBV-associated NPC with cancer development. Epigenetic marks for NPC diagnosis are urgently needed. In order to explore DNA methylation marks, we investigated DNA methylation of candidate genes in EBV-associated nasopharyngeal carcinoma. Methods We first employed methyl-capture sequencing and cDNA microarrays to compare the genome-wide methylation profiles of seven NPC tissues and five non-cancer nasopharyngeal epithelium (NNE) tissues. We found 150 hypermethylated CpG islands spanning promoter regions and down-regulated genes. Furthermore, we quantified the methylation rates of seven candidate genes using bisulfite amplicon sequencing for nine NPC and nine NNE tissues. Results All seven candidate genes showed significantly higher methylation rates in NPC than in NNE tissues, and the ratios (NPC/NNE) were in descending order as follows: ITGA4  >  RERG  >  ZNF671  >  SHISA3  >  ZNF549  >  CR2  >  RRAD . In particular, methylation levels of ITGA4, RERG, and ZNF671 could distinguish NPC patients from NNE subjects. Conclusions We identified the DNA methylation rates of previously unidentified NPC candidate genes. The combination of genome-wide and targeted methylation profiling by next-generation sequencers should provide useful information regarding cancer-specific aberrant methylation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1471-2407
1471-2407
DOI:10.1186/s12885-017-3482-3